Morphic Holding Inc (MORF): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Morphic Therapeutic (MORF)

The price-to-sales chart, which reflects the impact of Morphic Holding, Inc. (MORF) being acquired by a major holding company and the integration of its pipeline, has now reached a value of 2674.60, marking the metric's latest reading. This growth is driven by the patent protection of the MInT platform and FDA oversight. However, fierce competition in the VZK niche against industry behemoths creates risks of losing insurance reimbursements.

morphictx.com (MORF) - Multiplikator P/S saka 04.07.2022 nganti 26.04.2024

Rincian analitis perusahaan Morphic Holding Inc (MORF)

- kuotasi saiki lan rata-rata prakiraan nilai:
Rega bursa morphictx.com|MORF - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Morphic Holding Inc|MORF - Nilai Total Perusahaan
- indikator kapitalisasi buku:
Nilai Buku Saham Morphic|MORF - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku morphictx.com|MORF - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Koefisien Total Utang marang Modal Morphic Holding, Inc.|MORF - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Morphic Holding Corp|MORF - Gunggung utang perusahaan|Rasio utang marang aset resik Morphic Holding Inc|MORF - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Morphic|Likuiditas darurat morphictx.com
- indikator bathi lan kelipatan valuasi:
MORF - Bathi resik perusahaan|Bathi sing dikarepake Morphic Holding, Inc.|MORF - Pangali P/E|Rasio rega marang bathi mangsa ngarep Morphic Therapeutic|MORF - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Morphic Holding Inc|MORF - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Morphic|MORF - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku morphictx.com|MORF - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Morphic Holding, Inc.
- rincian pendapatan lan dodolan emiten:
MORF - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan morphictx.com|MORF - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Morphic Holding Inc
Ringkesan analitik perusahaan:morphictx.com, MORF
Barang utama Morphic Holding, Inc.

The integration of the Morphic Holding, Inc. (MORF) R&D platform into the Lilly structure shifts the company's business model into a stage of proprietary development synergy. This price-to-sales multiple determines the ratio of the business's market value to its annual sales, allowing investors to assess the fairness of asset valuations relative to actual cash flow by analyzing the risk of being overbought or undervalued through the price action on this chart.

Perusahaan pesaing

PHAT - Rega marang dodolan|Rasio rega marang pendapatan Terns Pharmaceuticals, Inc. TERN|Rasio kapitalisasi pasar marang pendapatan IRWD|CURX - Rasio rega marang pendapatan|Rasio rega marang dodolan IMRN|EVOK: Multiplikator P/S|Entero Therapeutics - Rasio kapitalisasi pasar marang pendapatan|RDHL (RedHill Biopharma Ltd) - Multiplikator P/S|Palisade Bio Inc. (PALI) - Koefisien rega marang pendapatan|Multiplikator P/S JAGX|Kapitalisasi marang pendapatan Biora Therapeutics, Inc BIOR